ImmunityBio, Inc. (IBRX) shares fell 2.8% to $7.91 at the September 16, 2026 close, a moderate decline from the prior close of $8.14. That close is the latest confirmed price for IBRX; a live quote was not available. BestStocks flagged the session as a major change for IBRX. The move is tied to price move up. Below, we break down what changed for IBRX, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
IBRX fell 2.8% to $7.91
IBRX fell 2.8% in its latest session, moving from $8.14 to $7.91.
Material / EarningsWeak confidence
Rel. volume
—
Calculating
Vs peers
—
No comparable peers
Market cap
—
Earnings in
47d
2026-11-03
Price chart
Aug 17 – Sep 17
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details
What it means for ImmunityBio, Inc. investors
For ImmunityBio, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: ImmunityBio, Inc. (IBRX) moved +3.24% from $7.40 to $7.64 on 2026-08-07; ImmunityBio, Inc. (IBRX) moved +4.17% from $6.96 to $7.25 on 2026-08-05. Weighing against that: Material negative event; Negative session, down 2.8%. BestStocks rates the overall signal quality weak (39/100). With earnings roughly 47 days out, the next report is the most likely near-term test of the move.
IBRX price reaction
IBRX last traded at $7.91, down $0.23 (-2.83%) from the previous close of $8.14. Over the past month the stock has ranged between $7.58 and $8.40, and it currently sits about 40% of the way up that band.
The bull and bear case for IBRX stock
Weighing the constructive signals against the risks, here is how the bull and bear case for ImmunityBio, Inc. (IBRX) lines up on the latest data.
▲ The bullish case
+ImmunityBio, Inc. (IBRX) moved +3.24% from $7.40 to $7.64 on 2026-08-07.
▼ The bearish case
−Material negative event.
−Negative session, down 2.8%.
−ImmunityBio, Inc. (IBRX) moved -6.94% from $8.07 to $7.51 on 2026-07-22.
−ImmunityBio fell 8.23% to $8.14 as part of a broader biotech sector selloff on Friday, July 10.
Bull vs bear balanceBearish Shift
BearishNeutralBullish
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
ImmunityBio, Inc. (IBRX) moved -2.94% from $8.15 to $7.91 on 2026-09-16. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume traded near its 5-day average, suggesting the move was not driven by unusual activity.
Material / Earnings2026-09-08+2.6%
ImmunityBio, Inc. (IBRX) moved +3.63% from $8.00 to $8.29 on 2026-09-08. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average at 1.3x.
Material / Earnings2026-08-28-4.2%
ImmunityBio, Inc. (IBRX) moved -3.13% from $8.31 to $8.05 on 2026-08-28. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average, indicating the move occurred on typical trading activity.
Material / Earnings2026-08-25+8.0%
ImmunityBio, Inc. (IBRX) moved +6.50% from $7.69 to $8.19 on 2026-08-25. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears to be technical, with IBRX reaching a new 30-day high.
Material / Earnings2026-08-17+4.6%
ImmunityBio, Inc. (IBRX) moved +5.04% from $7.54 to $7.92 on 2026-08-17. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average at 1.2x.
Activity2026-08-07+4.4%
ImmunityBio, Inc. (IBRX) moved +3.24% from $7.40 to $7.64 on 2026-08-07. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move occurred on volume near its 5-day average.
Activity2026-08-05+4.3%
ImmunityBio, Inc. (IBRX) moved +4.17% from $6.96 to $7.25 on 2026-08-05. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on volume near its 5-day average.
Material / Earnings2026-08-04-2.8%
ImmunityBio, Inc. (IBRX) reported EPS of $-0.22 vs. consensus estimate of $-0.08 for Q2 FY2026 on August 4, 2026, missing consensus by 175%.
Upcoming catalysts & outlook
Next earnings
2026-11-03
in 47 days
Thesis shift
Bearish Shift
bearish signal
Risk level
High
from change events
Frequently asked questions about IBRX
Why did ImmunityBio, Inc. (IBRX) stock move?
IBRX fell 2.8% to $7.91. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did IBRX stock fall?
IBRX lost 2.83% ($0.23) versus the prior close of $8.14, last trading at $7.91.
When is ImmunityBio, Inc.'s next earnings date?
IBRX's next earnings report is scheduled for 2026-11-03 — about 47 days away.
How BestStocks tracks IBRX
This page is generated automatically by BestStocks' change-detection system after price move up was detected and verified against independent data sources. It draws on 20 tracked change events for IBRX, cross-checked against the data sources listed below. A live intraday quote was not available, so price and volume figures are the confirmed end-of-day close from September 16, 2026 — not the current price — and the percentage move is that session's. They refresh once live quotes resume. For companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
